Psychedelics and AI promise the next breakthrough treatment for dementia
Spannr - 30-Mar-2023Benefits of psychedelic drugs or AI compounds may outperform clinical drugs with fewer side effects; clinical trials yet to confirm
Join the club for FREE to access the whole archive and other member benefits.
Business Consultant and Staff Writer at Spannr, Navy Veteran, Entrepreneur and Business Broker
Chelsea is a Navy veteran and serial entrepreneur who has lived around the globe. Her entrepreneurial path originated in CrossFit, where she discovered her obsession with helping people achieve personal transformation and the role of communities in health and happiness. That passion led her to the psychedelics startup space, where she helps people discover new ways of thinking, being, and living up to their potential. When not chasing a new idea, you can find Chelsea backcountry camping with camera in tow.
Visit website: https://spannr.com/about/chelsea
See alsoDetails last updated 23-Jun-2023
Benefits of psychedelic drugs or AI compounds may outperform clinical drugs with fewer side effects; clinical trials yet to confirm